Welcome to our dedicated page for CYPA news (Ticker: CYPA), a resource for investors and traders seeking the latest updates and insights on CYPA stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CYPA's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CYPA's position in the market.
Cyphaira Corp (CYPA) completed its corporate name change and began trading under the new ticker on OTC Markets on September 10, 2026.
The company, formerly known as Growth Stalk Holdings Corp and previously trading as GSTK, notes that the CUSIP remains unchanged and that the name and symbol change does not affect shares outstanding, shareholder rights, or reporting obligations. Shareholders are not required to take any action as brokerage accounts will automatically reflect the new name and symbol.
Cyphaira is now focused on enterprise decision-intelligence software, with its first product SolvixLMS designated production-ready in seven integrated suites and source-verified at 583,041 first-party source lines as of August 24, 2026, although no revenue has yet been recognized from it. The company is divesting four subsidiaries holding its legacy state-licensed cultivation and processing operations, with a Board-approved transaction expected to close upon transfer of the applicable state licenses.